1. Cutler, D., McClellan, M. & Newhouse, J. The Costs and Benefits of Intensive Treatment for Cardiovascular Disease (The American Enterprise Institute for Public Policy Research/Brookings Institution, Washington DC, December 1997).
2. Frank, R. G., Berndt, E. & Busch, S. H. Price Indexes for the Treatment of Depression (The American Enterprise Institute for Public Policy Research/Brookings Institution, Washington DC, December 1997).
3. Fagan, S. C. et al. Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke. Neurology 50 883–889 (1998).
4. Legg, R. F. et al. Cost benefit of sumatriptan to an employer. J. Occup. Environ. Med. 39, 652–657 (1997).
5. Lichtenberg, F. R. The effect of drug vintage on survival: micro evidence from Puerto Rico's medicaid program. National Bureau of Economic Research Working Paper No.10884. National Bureau of Economic Research web site
[online]
, (November 2004).